(Q37899936)

25 August 2017

1 reference

title

Hepatitis C virus infection in USA: an estimate of true prevalence (English)

1 reference

25 August 2017

1 reference

0 references

1 reference

5

Sammy Saab

1 reference

25 August 2017

Eric Chak

1

1 reference

25 August 2017

Andrew H Talal

series ordinal

2

1 reference

25 August 2017

Kenneth E Sherman

series ordinal

3

1 reference

25 August 2017

Eugene R Schiff

series ordinal

4

1 reference

25 August 2017

publication date

16 March 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

31

1 reference

25 August 2017

issue

8

1 reference

25 August 2017

page(s)

1090-1101

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Hepatitis C virus infection among prisoners in the California state correctional system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Hepatitis C in state correctional facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Antiretroviral therapy, hepatitis C virus, and AIDS mortality among San Francisco's homeless and marginally housed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Hepatitis C virus infection in san francisco’s HIV-infected urban poor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Prevalence of Hepatitis C virus infection in a sample of homeless veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Viral hepatitis and other infectious diseases in a homeless population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Hepatitis C virus infection among homeless men referred from a community clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Hepatitis C and substance use in a sample of homeless people in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Correlates of hepatitis C virus infections among injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Syringe exchange and risk of infection with hepatitis B and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Lessons learned from a peri-urban needle exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Detection of HCV RNA in saliva of patients with hepatitis C virus infection by using a highly sensitive test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Detection of hepatitis C virus RNA from gingival crevicular fluid and its relation to virus presence in saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Prevalence and risk factors for bloodborne exposure and infection in correctional healthcare workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Blood exposures and hepatitis C virus infections among emergency responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Hepatitis C in urban and rural public safety workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Hepatitis C screening and prevalence among urban and rural public safety workers in Oregon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Prevention of needlesticks in emergency medical system workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Hepatitis C screening and prevalence among urban public safety workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Seroprevalence of hepatitis B and hepatitis C among rural emergency medical care personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Risk factors for hepatitis C virus infection among health care personnel in a community hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Occupational risk for hepatitis C virus infection among New York City dentists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Elevated prevalence of hepatitis C infection in users of United States veterans medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Epidemiology of hepatitis C virus infection in American veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Outcomes of a Hepatitis C screening program at a large urban VA medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Guideline-concordant hepatitis C virus testing and notification among patients with and without mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Outcome of screening for hepatitis C virus infection based on risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Risk factors for hepatitis C virus infection among patients receiving health care in a Department of Veterans Affairs hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Prevalence of hepatitis C virus seropositivity among hospitalized US veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

45-year follow-up of hepatitis C virus infection in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

National surveillance of dialysis-associated diseases in the United States, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Serologic markers of viral hepatitis A, B, C, and D in patients with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Seroprevalence of viral hepatitis in an older nursing home population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Hepatitis B and hepatitis C in emergency department patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Prevalence and risk factors associated with hepatitis C in ED patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Prevalence of hepatitis C, hepatitis B, and human immunodeficiency virus in a Grand Rapids, Michigan emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Projecting future complications of chronic hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

Risk factors for hepatitis C virus infection among homeless adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02494.X

10.1111/J.1478-3231.2011.02494.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference